4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000748
Chief Discovery/Trans Medicine sold 38,443 shares at an average $34.69 ($1,333,529)
- Chief Discovery/Trans Medicine acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hamilton James C · Chief Discovery/Trans Medicine
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-03 | Sale : show line 1 in the form 10b5-1 | −3,500 | $31.81 | $111,335 | 178,734 | D |
| 2024-01-03 | Sale : show line 2 in the form 10b5-1 | −2,300 | $32.52 | $74,796 | 176,434 | D |
| 2024-01-03 | Sale : show line 3 in the form 10b5-1 | −500 | $33.30 | $16,650 | 175,934 | D |
| 2024-01-04 | Grant or award : show line 4 in the form 10b5-1 | +75,000 | 250,934 | D | ||
| 2024-01-05 | Sale : show line 5 in the form 10b5-1 | −1,800 | $34.00 | $61,200 | 249,134 | D |
| 2024-01-05 | Sale : show line 6 in the form 10b5-1 | −8,000 | $34.94 | $279,520 | 241,134 | D |
| 2024-01-05 | Sale : show line 7 in the form 10b5-1 | −12,343 | $35.65 | $440,028 | 228,791 | D |
| 2024-01-05 | Sale : show line 8 in the form 10b5-1 | −10,000 | $35.00 | $350,000 | 218,791 | D |
| Open-market sales · 38,443 sh · avg $34.69 · $1,333,529 | ||||||
Loading xslF345X05/wk-form4_1704502965.xml…